Axiom Investors’s Array Biopharma Inc ARRY Stock Holding History

Axiom Investors’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-74,885	Closed	-$3.47M	–	133
2019 Q2	$3.47M	Buy	74,885 +4,710	+7%	+$132K	0.1%	81
2019 Q1	$1.71M	Sell	70,175 -48,665	-41%	-$1.01M	0.05%	105
2018 Q4	$1.69M	Sell	118,840 -21,360	-15%	-$324K	0.06%	112
2018 Q3	$2.13M	Sell	140,200 -11,260	-7%	-$173K	0.06%	114
2018 Q2	$2.54M	Buy	+151,460	New	+$2.41M	0.08%	116

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Axiom Investors's ARRY Position: Q3 2019 in Review

Axiom Investors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 74,885 shares — an estimated $3.47M sold.

Axiom Investors first reported a position in ARRY in Q2 2018 and held it in 5 quarters. The position peaked at $3.47M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Axiom Investors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Axiom Investors sold 74,885 Array Biopharma Inc shares in Q3 2019, an estimated $3.47M.
Axiom Investors first reported a position in Array Biopharma Inc in Q2 2018 and held it in 5 quarters.
Axiom Investors's Array Biopharma Inc position peaked at $3.47M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Axiom Investors's 13F filing for Q3 2019, filed 13 Nov 2019.